Parallax Volatility Advisers’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,447
Closed -$261K 1611
2025
Q2
$261K Buy
2,447
+1,813
+286% +$183K ﹤0.01% 1284
2025
Q1
$57.7K Sell
634
-23,193
-97% -$2.6M ﹤0.01% 1390
2024
Q4
$2.72M Buy
23,827
+15,370
+182% +$1.75M 0.01% 1044
2024
Q3
$1M Sell
8,457
-14,382
-63% -$1.32M ﹤0.01% 1354
2024
Q2
$1.84M Sell
22,839
-15,990
-41% -$1.46M ﹤0.01% 1072
2024
Q1
$3.58M Buy
38,829
+12,683
+49% +$1.22M 0.01% 841
2023
Q4
$2.76M Sell
26,146
-2,652
-9% -$267K 0.01% 1059
2023
Q3
$3.13M Sell
28,798
-16,083
-36% -$1.78M 0.01% 933
2023
Q2
$4.84M Buy
44,881
+34,940
+351% +$3.93M 0.01% 798
2023
Q1
$1.24M Sell
9,941
-36,175
-78% -$4.97M ﹤0.01% 1410
2022
Q4
$6.93M Sell
46,116
-976
-2% -$150K 0.01% 910
2022
Q3
$6.35M Buy
47,092
+28,923
+159% +$4.42M 0.01% 921
2022
Q2
$2.71M Sell
18,169
-51,849
-74% -$7.92M ﹤0.01% 1233
2022
Q1
$11.9M Buy
+70,018
New +$11.8M 0.01% 679

Other funds holding BNTX

Parallax Volatility Advisers's BNTX Position: Q3 2025 in Review

Parallax Volatility Advisers sold out of BioNTech (BNTX) in Q3 2025, closing a stake of 2,447 shares — an estimated $261K sold.

Parallax Volatility Advisers first reported a position in BNTX in Q1 2022 and held it in 14 quarters. The position peaked at $11.9M in Q1 2022. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

  • Parallax Volatility Advisers reported no remaining BioNTech position as of Q3 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 2,447 BioNTech shares in Q3 2025, an estimated $261K.
  • Parallax Volatility Advisers first reported a position in BioNTech in Q1 2022 and held it in 14 quarters.
  • Parallax Volatility Advisers's BioNTech position peaked at $11.9M in Q1 2022.
  • 254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Parallax Volatility Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.